Idiopathic Normal Pressure Hydrocephalus (INPH)
11
3
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Acetazolamide Trial in Normal Pressure Hydrocephalus
Transcranial Ultrasound Assessment of Cerebral Pulsatility in Shunt Decision-making for Suspected Idiopathic Normal Pressure Hydrocephalus: a Prospective Cohort Study
Unsteady Gait in Older People May be a Common and Treatable Neurological Disease Associated With Increased Mortality
Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Functional Outcomes After LumbOpenitoneal Shunt Placement UndeR Local Anesthesia for Patients With Idiopathic Normal preSsure Hydrocephalus (FLOURISH) Trial
Efficacy in iNPH Shunting (PENS) Trial
Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)
The Pilot Study of Medical Device-Neuclare for Patients With Idiopathic Normal Pressure Hydrocephalus (iNPH)
Walking Pattern Characteristics in Normal Pressure Hydrocephalus
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial
Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten